Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ONON
NYSE:ONONLuxury

Is It Time To Reconsider On Holding (ONON) After Recent Share Price Weakness?

If you are wondering whether On Holding's current share price properly reflects its potential, the starting point is understanding how the market is valuing the business today. The stock closed at US$39.05, with returns of a 1% decline over 7 days, a 13.8% decline over 30 days, a 16.8% decline year to date, a 17.0% decline over 1 year, and a 42.7% gain over 3 years, which hints that the market's view of its prospects and risks has shifted over time. Recent news coverage has focused on On...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

A Look At Skyward Specialty Insurance Group (SKWD) Valuation After Recent Share Price Pullback

Skyward Specialty Insurance Group (SKWD) has drawn attention after recent trading saw the share price around $42.83, with returns weaker over the past month and the past 3 months compared with the prior 3 years. See our latest analysis for Skyward Specialty Insurance Group. For context, the 1 day share price return of a 4.9% decline and the 90 day share price return of a 17.3% decline sit against a 3 year total shareholder return of 120.1%. This suggests that recent momentum has cooled after...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Q4 Results And MRD Growth

Adaptive Biotechnologies (ADPT) is back on investor radar after fourth quarter results topped expectations, supported by its Minimal Residual Disease business and growing clonoSEQ adoption, while recent insider sales largely reflected tax related share transactions. See our latest analysis for Adaptive Biotechnologies. At a share price of US$13.28, Adaptive Biotechnologies has seen a 1 month share price return of a 17.21% decline and a 90 day share price return of a 19.52% decline. However,...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Is Down 5.1% After Market Value Slides Despite Solid Fundamentals Has The Bull Case Changed?

In the past week, ResMed’s share price weakness has erased about US$3.30 billion from its market value, leaving the company at roughly US$34.00 billion despite reports that its operating performance and financial condition remain solid. This disconnect between market sentiment and underlying business health raises questions about whether recent trading reflects short-term emotion rather than changes in ResMed’s long-term outlook. Against this backdrop of recent market value erosion despite...
NYSE:SAM
NYSE:SAMBeverage

Is It Time To Reconsider Boston Beer Company (SAM) After Its Recent Share Price Rebound

If you have been wondering whether Boston Beer Company stock still offers fair value at around US$232.89, you are not alone. The answer depends heavily on which valuation lens you use. The share price has delivered a 16.5% return year to date, with a 0.4% move over the last week, a 5.9% decline over 30 days, and a 6.3% return over the past year, which can change how investors weigh growth potential against risk. These moves sit against a longer backdrop where the stock shows a 26.8% decline...
TSX:EDV
TSX:EDVMetals and Mining

Assessing Endeavour Mining’s Valuation As BlackRock Ownership Shifts And Buybacks Reshape The Share Base

Recent filings show BlackRock adjusting its voting stake in Endeavour Mining (TSX:EDV) alongside continued share buybacks that reduce the share count, developments that together reshape the ownership base and may influence how investors view the stock. See our latest analysis for Endeavour Mining. Those ownership shifts and ongoing buybacks come after a strong period for holders, with 1 year total shareholder return of 147.4% and 5 year total shareholder return of 281.73%. However, the recent...
OTCPK:MBLU
OTCPK:MBLUBanks

Morris State Bancshares (OTCPK:MBLU) Earnings Jump 21.5% Challenges Cautious Growth Narratives

Morris State Bancshares (MBLU) has wrapped up FY 2025 with fourth quarter total revenue of about US$51.6 million and net income of roughly US$17.3 million, translating into basic EPS of US$1.63 and rounding out trailing twelve month EPS of US$2.49 on revenue of about US$71.4 million. Over the past few quarters, the company has seen quarterly revenue move from US$15.9 million and EPS of US$0.46 in Q1 2025 to US$17.2 million and EPS of US$0.57 in Q2, before landing at US$51.6 million and...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Expands Mass Spec Reach And Builds India Research Ties

Roche Holding's Ionify steroid assays for mass spectrometry have received U.S. FDA moderate complexity classification, widening access to advanced steroid hormone testing in clinical labs. Roche Pharma India has signed an MoU with NIPER Raebareli to collaborate on pharmaceutical education and research. These developments relate to both Roche's diagnostics portfolio and its global R&D footprint, including activity in India. Roche Holding (SWX:ROG) is drawing attention with regulatory...
TASE:ACRO
TASE:ACROConstruction

Kvutzat Acro (TASE:ACRO) Quarterly EPS Loss Challenges Bullish Profitability Narratives

Kvutzat Acro (TASE:ACRO) has just wrapped up FY 2025 with fourth quarter revenue of ₪148.2 million and a basic EPS loss of ₪0.17, capping a year in which trailing 12 month revenue came in at ₪656.4 million and EPS was ₪0.94 as earnings rose 188.3% over the last year. Over recent quarters the company has seen revenue move from ₪171.1 million in Q4 2024 to a peak of ₪210.3 million in Q3 2024 before ending FY 2025 at ₪148.2 million. Quarterly EPS shifted from ₪0.06 in Q4 2024 to ₪0.64 in Q2 2025...
ENXTPA:VLTSA
ENXTPA:VLTSARenewable Energy

Voltalia (ENXTPA:VLTSA) Valuation Reassessed After Sales Growth And Deeper Net Loss In Latest Results

Voltalia (ENXTPA:VLTSA) is back in focus after full year 2025 results showed sales of €588 million versus €520 million a year earlier, alongside a net loss of €128 million versus €21 million. See our latest analysis for Voltalia. The latest full year results seem to have sharpened attention on profitability, with the share price at €6.835 and a 7 day share price return of 7.47% contrasting with a year to date share price return of 16.29% decline and a 3 year total shareholder return of 51.66%...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Assessing FTAI Aviation (FTAI) Valuation After Analyst Upgrades And Strong Earnings Momentum

Recent analyst enthusiasm has pushed FTAI Aviation (FTAI) into the spotlight, with reports linking higher earnings estimates and long term prospects to the company’s revenue and earnings results. See our latest analysis for FTAI Aviation. At a share price of $240.49, FTAI Aviation has pulled back with a 14.06% 30 day share price return and 7.47% 7 day share price return, yet longer term momentum remains strong with a 1 year total shareholder return of 122.51% and a 3 year total shareholder...
XTRA:MRK
XTRA:MRKPharmaceuticals

Assessing Merck KGaA (XTRA:MRK) Valuation After Recent Share Price Momentum Shift

Merck KGaA (XTRA:MRK) has been on many watchlists after a recent stretch of weaker share performance, with the stock showing negative returns over the past month and the past 3 months. See our latest analysis for Merck KGaA. At a share price of €107.35, Merck KGaA’s recent 1 month share price return of 15.47% and year to date share price return of 11.50% indicate a change in momentum that corresponds with a weaker 1 year total shareholder return of 17.33% and lower 3 and 5 year total...
TSX:NEO
TSX:NEOChemicals

A Look At Neo Performance Materials (TSX:NEO) Valuation After Its Recent Share Price Surge

Recent share performance and business snapshot Neo Performance Materials (TSX:NEO) has drawn fresh attention after a strong past 3 months, with the share price up about 52%, building on a gain of roughly 16% over the past month. The company has a market value of about CA$1.03b and last closed at CA$23.84. Neo generates revenue of roughly $493.4m across rare earth magnetic powders, chemicals and oxides, and rare metals, serving customers in North America, Europe, China, Japan, and other...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

Flatiron Benchtop Quantum Platform Could Be A Game Changer For FormFactor (FORM)

On March 11, 2026, FormFactor launched the Flatiron Dilution Refrigerator, a compact benchtop system capable of ~30 mK operation with integrated optical access, aiming to simplify millikelvin optical and electrical measurements for quantum research and chip-scale validation. The Flatiron’s horizontal, quick-access architecture and small footprint could materially reduce experimental overhead for quantum device teams, reinforcing FormFactor’s push deeper into quantum-enabling hardware. Next,...
OB:HAFNI
OB:HAFNIOil and Gas

Is It Too Late To Consider Hafnia (OB:HAFNI) After Its Strong Multi Year Share Price Run

Wondering whether Hafnia shares still offer value after a strong run, or if most of the upside is already in the price? This valuation review is built to help you frame that question clearly. The stock recently closed at NOK 67.2, with returns of 3.7% over 7 days, 5.6% over 30 days, 27.9% year to date, 51.6% over 1 year, and a very large gain over 5 years. These moves sit against a backdrop of ongoing interest in shipping and energy related names, as investors reassess risk and capital...
NasdaqGS:SMCI
NasdaqGS:SMCITech

A Look At Super Micro Computer (SMCI) Valuation After New AI Server And Data Platform Launches At NVIDIA GTC 2026

Super Micro Computer (SMCI) is back in focus after a busy week at NVIDIA GTC 2026, where it rolled out new Vera Rubin and Blackwell based AI servers, context memory storage, and integrated AI Data Platform solutions. See our latest analysis for Super Micro Computer. Despite the product-heavy week at GTC, SMCI’s 1-day share price return of 3.68% and 7-day share price return of 4.53% are both negative. However, the 3-year total shareholder return of 169.68% and 5-year total shareholder return...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Does Scholar Rock (SRRK) Offer Long-Term Value After Recent Share Price Weakness?

If you are wondering whether Scholar Rock Holding's current share price matches what the business may be worth, you will want to look closely at how its value stacks up across different methods. The stock closed at US$39.79, with returns of a 7.9% decline over 7 days, a 13.5% decline over 30 days, a 7.0% decline year to date, a 17.1% gain over 1 year, and a very large 3-year gain of 334.9%, alongside a 22.4% loss over 5 years. Those mixed returns hint that sentiment around Scholar Rock...
TASE:CEL
TASE:CELWireless Telecom

Cellcom Israel (TASE:CEL) Q4 Net Income Surge Tests Bearish Profitability Narratives

Cellcom Israel (TASE:CEL) has wrapped up FY 2025 with fourth quarter revenue of ₪1.1b and basic EPS of ₪2.11, capping a year in which trailing twelve month revenue reached ₪4.2b and EPS came in at ₪3.35 alongside a 68.9% rise in net earnings over the past year. Over recent quarters the company has seen revenue move from ₪1.1b in Q4 2024 to ₪1.1b in Q4 2025, while quarterly basic EPS shifted from ₪0.33 to ₪2.11. This may encourage investors to focus on how the stronger net margin profile...
TSE:6740
TSE:6740Electronic

A Look At Japan Display (TSE:6740) Valuation After A Sharp Momentum Driven Share Price Surge

Japan Display (TSE:6740) drew attention after its stock jumped 53.16% in after hours trading on March 16, 2026. Heavy volume and sector chatter around display supply chains fueled speculative buying. See our latest analysis for Japan Display. The latest after hours move follows a 313.04% 30 day share price return and a 400% 90 day share price return. The 1 year total shareholder return of 427.78% indicates that momentum has been building over a longer period. If this kind of fast move in a...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Is It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide

If you have been wondering whether Veeva Systems at around US$184 per share looks like a bargain or not, this breakdown will help you weigh the price against the underlying business. The stock has seen mixed returns, with a 5.7% gain over the last 30 days, set against a 22.4% decline over the past year and a 16.2% decline year to date. Recent coverage has focused on how investors are reassessing higher growth software names, with attention on valuation discipline and selectivity across...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is Luckin Coffee (OTCPK:LKNC.Y) Attractive After Recent Share Price Weakness?

If you are wondering whether Luckin Coffee is priced attractively today or running ahead of itself, this breakdown will help you frame what the current share price might be implying. Over the last year, the stock has returned 0.9%, after a 3.7% decline over the past week and a 6.9% decline over the past month from a last close of US$33.92. These moves may have shifted how some investors think about its potential and risk. Recent coverage around Luckin Coffee has focused on its position in...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Is It Too Late To Consider Sandisk (SNDK) After A 7x One Year Surge?

Wondering if Sandisk at US$753.69 is priced for perfection or still offers value? This article walks through what the market may be implying about the stock today. The share price now reflects a 15.0% return over the past week, 20.3% over the last 30 days and a very large 1 year return of more than 7x. This naturally raises questions about how much optimism is already built in. Recent news coverage has focused on Sandisk within broader discussions of high growth tech names, where rapid share...
NYSE:FBIN
NYSE:FBINBuilding

Has Fortune Brands Innovations (FBIN) Fallen Too Far After Recent 12‑Month Share Price Slide

Wondering whether Fortune Brands Innovations at around US$41.35 is starting to look like value or still has more risk priced in? This article walks through the key signals to help you frame that question. The stock has seen a 8.5% decline over the last 7 days, a 19.4% decline over the last 30 days, and is tracking 18.8% lower year to date, with a 33.6% decline over the last 12 months and longer term 24.0% and 41.0% declines over 3 and 5 years respectively. These moves have attracted...
TSX:FFH
TSX:FFHInsurance

Why Fairfax Financial (TSX:FFH) Is Up 6.0% After Completing Its US$1.15 Billion Share Buyback Program

Fairfax Financial Holdings has completed a share repurchase program announced on September 26, 2025, buying back 691,435 shares, or 3.24% of its equity, for US$1.15 billion between October 1, 2025 and March 6, 2026. This sizeable reduction in share count sharpens attention on how Fairfax’s capital deployment choices may influence future earnings per share and perceived valuation gaps. We will now explore how this large completed buyback may reshape Fairfax’s investment narrative,...